<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
    <channel>
    <title>PM Live RSS Feed :: Pharmaceutical Industry RSS</title>
 <link>http://www.pmlive.com</link>
        <description>PM Live RSS Feed :: Pharmaceutical Industry RSS</description>
        <language>en-gb</language>
        
		<item>
  <title>MHRA chair Breckenridge to advise UK on healthcare ethics</title>
  <link>http://www.pmlive.com/pharma_news/mhra_chair_breckenridge_advise_uk_healthcare_ethics_404818</link>
 <description><![CDATA[ 
Sir Alasdair Breckenridge appointed first chair of the Emerging Science and Bioethics Advisory Committee
 - 23/05/2012]]></description>
  <pubDate>Wed, 23 May 2012 11:05:40 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/mhra_chair_breckenridge_advise_uk_healthcare_ethics_404818</guid>
</item>

 
<item>
  <title>China has more pharma sales reps than US for first time</title>
  <link>http://www.pmlive.com/pharma_news/china_overtakes_us_number_pharma_sales_reps_404785</link>
 <description><![CDATA[ 
Reflects increasing industry focus on emerging markets
 - 23/05/2012]]></description>
  <pubDate>Wed, 23 May 2012 10:24:08 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/china_overtakes_us_number_pharma_sales_reps_404785</guid>
</item>

 
<item>
  <title>Industry 'should work closer with payers on drug development'</title>
  <link>http://www.pmlive.com/pharma_news/industry_payers_collaboration_drug_development_404802</link>
 <description><![CDATA[ New report says early collaboration could address lack of knowledge regarding risk in biopharmaceutical development - 23/05/2012]]></description>
  <pubDate>Wed, 23 May 2012 10:42:54 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/industry_payers_collaboration_drug_development_404802</guid>
</item>

 
<item>
  <title>Abbott faces FDA delay for Humira as colitis treatment</title>
  <link>http://www.pmlive.com/pharma_news/abbott_fda_delay_biologic_humira_colitis_drug_404760</link>
 <description><![CDATA[ <p>US regulator wants more information on the biologic drug</p>  - 23/05/2012]]></description>
  <pubDate>Wed, 23 May 2012 09:49:38 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/abbott_fda_delay_biologic_humira_colitis_drug_404760</guid>
</item>

 
<item>
  <title>GE Healthcare signs cell therapy research partnership</title>
  <link>http://www.pmlive.com/pharma_news/ge_healthcare_cell_therapy_research_partnership_karolinska_404704</link>
 <description><![CDATA[ <p>Will work with Karolinska University Hospital to investigate clinical technology and workflow needs</p>  - 23/05/2012]]></description>
  <pubDate>Tue, 22 May 2012 16:26:40 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/ge_healthcare_cell_therapy_research_partnership_karolinska_404704</guid>
</item>

 
<item>
  <title>The early bird: planning ahead in communications</title>
  <link>http://www.pmlive.com/pharma_news/the_early_bird_planning_ahead_communications_403850</link>
 <description><![CDATA[ EPSCP has emerged as a major impetus in pharmaceutical communications development. What are the important considerations and benefits from doing it successfully?  - 23/05/2012]]></description>
  <pubDate>Fri, 18 May 2012 12:14:28 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/the_early_bird_planning_ahead_communications_403850</guid>
</item>

 
<item>
  <title>PRA expands its European operations with new UK and Dutch offices</title>
  <link>http://www.pmlive.com/pharma_news/pra_expands_european_cro_operations_404468</link>
 <description><![CDATA[ Will open new base in Utrecht and relocate its existing Reading, UK offices to a larger site - 22/05/2012]]></description>
  <pubDate>Tue, 22 May 2012 11:05:45 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/pra_expands_european_cro_operations_404468</guid>
</item>

 
<item>
  <title>Daiichi to research cancer drugs with Japan’s National Cancer Centre</title>
  <link>http://www.pmlive.com/pharma_news/daiichi_research_cancer_drugs_japan_national_cancer_centre_404464</link>
 <description><![CDATA[ 
Deal also covers promotion of public health
 - 22/05/2012]]></description>
  <pubDate>Tue, 22 May 2012 10:51:20 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/daiichi_research_cancer_drugs_japan_national_cancer_centre_404464</guid>
</item>

 
<item>
  <title>Boehringer Ingelheim's Dr Susan Anton joins Icon</title>
  <link>http://www.pmlive.com/pharma_news/icon_cro_boehringer_ingelheim_dr_susan_anton_404453</link>
 <description><![CDATA[ The CRO also appoints Dr Pui Leung, boosting its early phase and epidemiology and risk management teams - 22/05/2012]]></description>
  <pubDate>Tue, 22 May 2012 10:45:54 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/icon_cro_boehringer_ingelheim_dr_susan_anton_404453</guid>
</item>

 
<item>
  <title>Xarelto backed for ACS ahead of FDA advisory panel</title>
  <link>http://www.pmlive.com/pharma_news/xarelto_backed_acs_ahead_fda_advisory_panel_404404</link>
 <description><![CDATA[ Documents released showing agency supports Johnson &amp; Johnson/Bayer's drug in extra indication - 22/05/2012]]></description>
  <pubDate>Tue, 22 May 2012 10:03:30 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/xarelto_backed_acs_ahead_fda_advisory_panel_404404</guid>
</item>

 
    </channel>
</rss>
